Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking

NCT00218465 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Dependence

Interventions

DRUG: GW468816
DRUG: Placebo Comparator: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]